FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2781220801> ?p ?o ?g. }

• W2781220801 endingPage "60" @default.
• W2781220801 startingPage "53" @default.
• W2781220801 abstract "Purpose – to compare the efficacy of urokinase and urokinase combined with low molecular weight heparin (Cibor 2500 mg) for the treatment of critical limb ischemia in diabetic foot.Material and methods. The first group of studies (IG 1) – 39 patients, received 1,0–0,05 million I U/day f or 20–26 days urokinase along with treatment protocol. The second group (IG 2) – 19 patients received treatment similar to one IG but while taking Cibor. Control Group (CG, 11 patients) recruited retrospectively. It was compared the dynamics of level of fibrinogen, TcPO2 and dynamics of ulcer healing (assessed by the beginning of treatment, at 10 and 20 days). Results. In both experimental groups dynamic of fibrinogen was statistically better than in the CG (p < 0,01) – its level reduced in an IG 1 and 2 f rom (4.55 ± 1.64) g/l and (4.82 ± 1.10) g/l to (2.43 ± 1.03) g/l and (2.57 ± 0.82) g/l after 20 days respectively. In CG level of fibrinogen decreased from (4.70 ± 1.18) g/l to (3.93 ± 1.01) g/l. There was no significant difference in the dynamic of fibrinogen between 1 and 2 IG. Just significantly (p <0.01) improved level of TcPO2 1 and 2 IG (f rom (10.36 ± 3.02) and (9.21 ± 3.05) mm Hg on the beginning to (19.26 ± 6.54) and (23.65 ± 3.12) mm Hg . at the end of treatment ) compared with the dynamics in the CG ((13. 50 ± 2.66) mm Hg at beginning and (14.80 ± 2.71) mm Hg at the end of treatment) . But with the additional use Cibor TcPO2 was statistically better on 10th ((15.32 ± 3.41) mm Hg vs (13.38 ± 3.36) mm Hg . ). and on the twentieth day. In the hospital after stabilizing among patients of IG 1 13 (33.33%) amputations were performed, including 3 – at the level of the famur, 3 – at the level of the shin, 7 – at the level of the foot. In IG 2 6 (31.58%) patients were perf ormed amputations , including 1- at lev el of the lower third of the femur, 1 – at the level of the shin, 4 – foot amputation level. In CG conducted 7 (64%), including 2 – at hip level, 2 – at the level of shin and 3 foot amputation level. Conclusions. Thus demonstrated the efficacy of a combination of urokinase with LMWH on the healing of ulcers in patients with critical ischemia of diabetic foot syndrome by reducing fibrinogen levels and improve blood circulation in the lower limbs." @default.
• W2781220801 created "2018-01-05" @default.
• W2781220801 creator A5012522926 @default.
• W2781220801 date "2014-03-24" @default.
• W2781220801 modified "2023-09-25" @default.
• W2781220801 title "Combined fibrinolytic therapy for critical limb ischemia in patients with diabetic foot syndrome" @default.
• W2781220801 cites W1854281195 @default.
• W2781220801 cites W2132250384 @default.
• W2781220801 doi "https://doi.org/10.25284/2519-2078.1(66).2014.85597" @default.
• W2781220801 hasPublicationYear "2014" @default.
• W2781220801 type Work @default.
• W2781220801 sameAs 2781220801 @default.
• W2781220801 citedByCount "0" @default.
• W2781220801 crossrefType "journal-article" @default.
• W2781220801 hasAuthorship W2781220801A5012522926 @default.
• W2781220801 hasBestOaLocation W27812208011 @default.
• W2781220801 hasConcept C126322002 @default.
• W2781220801 hasConcept C134018914 @default.
• W2781220801 hasConcept C2776892390 @default.
• W2781220801 hasConcept C2777466421 @default.
• W2781220801 hasConcept C2777858829 @default.
• W2781220801 hasConcept C2779036427 @default.
• W2781220801 hasConcept C2781099653 @default.
• W2781220801 hasConcept C3018348675 @default.
• W2781220801 hasConcept C541997718 @default.
• W2781220801 hasConcept C555293320 @default.
• W2781220801 hasConcept C71924100 @default.
• W2781220801 hasConcept C90924648 @default.
• W2781220801 hasConceptScore W2781220801C126322002 @default.
• W2781220801 hasConceptScore W2781220801C134018914 @default.
• W2781220801 hasConceptScore W2781220801C2776892390 @default.
• W2781220801 hasConceptScore W2781220801C2777466421 @default.
• W2781220801 hasConceptScore W2781220801C2777858829 @default.
• W2781220801 hasConceptScore W2781220801C2779036427 @default.
• W2781220801 hasConceptScore W2781220801C2781099653 @default.
• W2781220801 hasConceptScore W2781220801C3018348675 @default.
• W2781220801 hasConceptScore W2781220801C541997718 @default.
• W2781220801 hasConceptScore W2781220801C555293320 @default.
• W2781220801 hasConceptScore W2781220801C71924100 @default.
• W2781220801 hasConceptScore W2781220801C90924648 @default.
• W2781220801 hasIssue "1(66)" @default.
• W2781220801 hasLocation W27812208011 @default.
• W2781220801 hasOpenAccess W2781220801 @default.
• W2781220801 hasPrimaryLocation W27812208011 @default.
• W2781220801 hasRelatedWork W1966106481 @default.
• W2781220801 hasRelatedWork W2024722853 @default.
• W2781220801 hasRelatedWork W2047027526 @default.
• W2781220801 hasRelatedWork W2133914046 @default.
• W2781220801 hasRelatedWork W2332190206 @default.
• W2781220801 hasRelatedWork W2373402090 @default.
• W2781220801 hasRelatedWork W2400180505 @default.
• W2781220801 hasRelatedWork W2421708340 @default.
• W2781220801 hasRelatedWork W2778717811 @default.
• W2781220801 hasRelatedWork W2781220801 @default.
• W2781220801 hasVolume "0" @default.
• W2781220801 isParatext "false" @default.
• W2781220801 isRetracted "false" @default.
• W2781220801 magId "2781220801" @default.
• W2781220801 workType "article" @default.